T. Rowe Price Group, Inc(NASDAQ:TROW) 
T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity ...
Website: http://www.troweprice.com
Founded: 1937
Full Time Employees: 7,635
Sector: Financial Services
Industry: Asset Management
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2011-12-31 | 2010-12-31 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2007-12-31 | 2007-03-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2004-06-30 | 2003-12-31 |
|---|
Balance Sheets:
Quarterly
Annual
| Unit: USD |
|---|
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2017-03-31 |
|---|---|
cash flows from operating activities | |
net income | 385.9 |
adjustments to reconcile net income to net cash from operating activities | |
depreciation, amortization and impairment of property, equipment and software | |
amortization and impairment of acquisition-related assets and retention arrangements | |
fair value remeasurement of contingent consideration liability | |
stock-based compensation expense | 36.8 |
net gains recognized on investments | -46.2 |
net (investments) redemptions in investment products used to economically hedge deferred compensation liabilities | |
net change in securities held by consolidated investment products | |
other changes in assets and liabilities | 363.6 |
net cash from operating activities | 728.1 |
capital expenditures | 0 |
free cash flows | 728.1 |
cash flows from investing activities | |
purchases of sponsored investment products | |
dispositions of sponsored investment products | |
net cash of investment products upon deconsolidation | |
additions to property, equipment and software | |
other investing activity | |
net cash from investing activities | 52.9 |
cash flows from financing activities | |
repurchases of common stock | |
common share issuances under stock-based compensation plans | |
dividends paid to common stockholders and equity-unit holders | |
net distributions to non-controlling interests in consolidated entities | |
net subscriptions from redeemable non-controlling interest holders | |
net cash from financing activities | -405.1 |
effect of exchange rate changes on cash and cash equivalents of consolidated investment products | |
net change in cash and cash equivalents during year | |
cash and cash equivalents at beginning of year, including 63.1 million at december 31, 2024, 77.2 million at december 31, 2023, and 119.1 million at december 31, 2022, held by consolidated investment products | |
cash and cash equivalents at end of year, including 39.1 million at december 31, 2025, 63.1 million at december 31, 2024, and 77.2 million at december 31, 2023, held by consolidated investment products | |
net losses recognized on other investments | |
additions to property and equipment | |
dividends paid to common stock and equity-award holders | |
net subscriptions (redemptions) from redeemable non-controlling interest holders | |
cash and cash equivalents at beginning of year, including 77.2 million at december 31, 2023, 119.1 million at december 31, 2022 and 101.1 million at december 31, 2021 held by consolidated investment products | |
cash and cash equivalents at end of year, including 63.1 million at december 31, 2024, 77.2 million at december 31, 2023, and 119.1 million at december 31, 2022, held by consolidated investment products | |
net investments in sponsored investment products used to economically hedge supplemental savings plan liability | |
net change in securities held by consolidated sponsored investment products | |
net cash of sponsored investment products on consolidation | |
acquisition, net of cash acquired | |
effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products | |
net change in cash and cash equivalents during period | 375.9 |
cash and cash equivalents at beginning of period, including 119.1 million at december 31, 2022, 101.1 million at december 31, 2021 and 104.8 million at december 31, 2020 held by consolidated sponsored investment products | |
cash and cash equivalents at end of period, including 77.2 million at december 31, 2023, 119.1 million at december 31, 2022, and 101.1 million at december 31, 2021, held by consolidated sponsored investment products | |
net gains recognized on other investments | |
cash and cash equivalents at beginning of period, including 101.1 million at december 31, 2021, 104.8 million at december 31, 2020 and 76.5 million at december 31, 2019 held by consolidated sponsored investment products | |
cash and cash equivalents at end of period, including 119.1 million at december 31, 2022, 101.1 million at december 31, 2021, and 104.8 million at december 31, 2020, held by consolidated sponsored investment products | |
net investments in t. rowe price investment products used to economically hedge supplemental savings plan liability | |
net change in securities held by consolidated t. rowe price investment products | |
purchases of t. rowe price investment products | |
dispositions of t. rowe price investment products | |
net cash of t. rowe price investment products on consolidation | |
effect of exchange rate changes on cash and cash equivalents of consolidated t. rowe price investment products | |
cash and cash equivalents at beginning of period, including 104.8 million at december 31, 2020, 76.5 million at december 31, 2019 and 70.1 million at december 31, 2018 held by consolidated t. rowe price investment products | |
cash and cash equivalents at end of period, including 101.1 million at december 31, 2021, 104.8 million at december 31, 2020, and 76.5 million at december 31, 2019, held by consolidated t. rowe price investment products | |
depreciation, amortization and impairment of property and equipment | |
net subscriptions received from redeemable non-controlling interest holders | |
cash and cash equivalents at beginning of period, including 76.5 million at december 31, 2019, 70.1 million at december 31, 2018 and 103.1 million at december 31, 2017 held by consolidated t. rowe price investment products | |
cash and cash equivalents at end of period, including 104.8 million at december 31, 2020, 76.5 million at december 31, 2019, and 70.1 million at december 31, 2018, held by consolidated t. rowe price investment products | |
realized gains on dispositions of available-for-sale t. rowe price investment products | |
gains recognized upon transfer of an investment in a t. rowe price mutual fund from available-for-sale to held as trading | |
cash and cash equivalents at beginning of period, including 70.1 million at december 31, 2018 and 103.1 million at december 31, 2017 held by consolidated t. rowe price investment products | |
cash and cash equivalents at end of period, including 76.5 million at december 31, 2019, 70.1 million at december 31, 2018, and 103.1 million at december 31, 2017, held by consolidated t. rowe price investment products | |
depreciation and amortization of property and equipment | 35.6 |
net investments in t. rowe price investment products to economically hedge supplemental savings plan liability | |
net change in trading securities held by consolidated t. rowe price investment products | |
changes in accounts receivable and accrued revenue | |
changes in payables and accrued liabilities | |
dispositions t. rowe price investment products | |
net cash from provided by financing activities | |
cash and cash equivalents at beginning of period, including 103.1 million at december 31, 2017 and 65.6 million at december 31, 2016 held by consolidated t. rowe price investment products | |
cash and cash equivalents at end of period, including 70.1 million at december 31, 2018, 103.1 million at december 31, 2017, and 65.6 million at december 31, 2016, held by consolidated t. rowe price investment products | |
investments in t. rowe price mutual funds held as trading to economically hedge supplemental savings plan liability | |
purchases of available-for-sale t. rowe price investment products | |
dispositions of available-for-sale t. rowe price investment products | |
cash and cash equivalents at beginning of year | 1,204.9 |
cash and cash equivalents at end of period, including 65.6 million at december 31, 2016, and 103.1 million at december 31, 2017, held by consolidated t. rowe price investment products | |
cash flow attributable to t. rowe price group | |
realized gains on dispositions of available-for-sale sponsored investment portfolios | -47.6 |
net change in trading securities held by consolidated sponsored investment portfolios | |
effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment portfolios | |
cash and cash equivalents at end of period | 1,580.8 |
realized gains on the dispositions of sponsored funds | |
purchases of available-for-sale sponsored fund investments | |
dispositions of available-for-sale sponsored fund investments | |
net cash of sponsored investment portfolios on consolidation | |
dividends | |
cash and cash equivalents at end of year, including 65.6 million held by consolidated sponsored investment portfolios at december 31, 2016 | |
investments in sponsored funds | |
dispositions of sponsored funds | |
investments in debt securities held by savings bank subsidiary | |
proceeds from debt securities held by savings bank subsidiary | |
excess tax benefits from stock-based compensation plans | |
change in savings bank subsidiary deposits | |
cash and cash equivalents | |
net change during year | |
at beginning of year | |
at end of year | |
intangible asset amortization | |
net change in trading securities held by consolidated investment portfolios | |
changes in securities held by consolidated sponsored investment portfolios | |
investment in uti asset management company limited | |
other investments made | |
proceeds from other investments | |
other than temporary impairments of investments in sponsored mutual funds | |
investments in sponsored mutual funds | |
dispositions of sponsored mutual funds | |
investments in debt securities by savings bank subsidiary | |
dividends paid to stockholders | |
other investment activity | |
stock options exercised and restricted shares vested | |
increase in savings bank subsidiary deposits | |
stock options exercised | |
debt principal repaid | |
net increase during year | |
dispositions of debt securities by savings bank subsidiary | |
repurchases of common shares | |
savings bank subsidiary deposits |